https://vasomune.com/publication/vasculotide-reduces-pulmonary-hyperpermeability-in-experimental-pneumococcal-pneumonia/2019-01-08T11:27:47-05:00https://vasomune.com/publication/effects-of-a-synthetic-peg-ylated-tie-2-agonist-peptide-on-endotoxemic-lung-injury-and-mortality/2019-01-08T11:26:39-05:00https://vasomune.com/publication/the-tie2-agonist-vasculotide-protects-lungs-from-pneumonia-induced-barrier-disruption/2019-01-08T11:27:04-05:00https://vasomune.com/publication/the-tie2-agonist-vasculotide-rescues-mice-from-influenza-virus-infection/2019-01-08T11:27:23-05:00https://vasomune.com/publication/pharmacological-tie2-activation-in-kidney-transplantation/2019-01-08T11:25:51-05:00https://vasomune.com/publication/the-synthetic-tie2-agonist-peptide-vasculotide-protects-renal-vascular-barrier-function-in-experimental-acute-kidney-injury/2019-01-16T10:27:28-05:00https://vasomune.com/publication/vasculotide-an-angiopoietin-1-mimetic-reduces-pulmonary-vascular-leakage-and-preserves-microcirculatory-perfusion-during-cardiopulmonary-bypass-in-rats/2019-01-08T11:25:26-05:00https://vasomune.com/publication/mitigating-microvascular-leak-during-fluid-resuscitation-of-hemorrhagic-shock/2019-01-16T10:27:06-05:00https://vasomune.com/publication/vasculotide-an-angiopoietin-1-mimetic-restores-microcirculatory-perfusion-and-microvascular-leakage-and-decreases-fluid-resuscitation-requirements-in-hemorrhagic-shock/2019-01-08T11:24:58-05:00https://vasomune.com/publication/vasculotide-an-angiopoietin-1-mimetic-reduces-acute-skin-ionizing-radiation-damage-in-a-preclinical-mouse-model/2019-01-08T11:24:13-05:00https://vasomune.com/publication/the-synthetic-tie2-agonist-peptide-vasculotide-protects-against-vascular-leakage-and-reduces-mortality-in-murine-abdominal-sepsis/2019-01-08T11:23:43-05:00https://vasomune.com/publication/acceleration-of-diabetic-wound-healing-by-an-angiopoietin-peptide-mimetic-van-slyke-p-alami-j-martin-d-kuliszewski-m-leong-poi-h-sefton-mv-dumont-d/2019-01-16T10:28:07-05:00https://vasomune.com/publication/angiopoietins-and-tie2-in-vascular-inflammation/2019-01-08T11:22:52-05:00https://vasomune.com/publication/endothelial-activation-the-ang-tie-axis-in-sepsis/2019-01-08T11:22:20-05:00https://vasomune.com/publication/pharmacological-tie2-activation-in-kidney-transplantation-2/2019-01-08T11:21:50-05:00https://vasomune.com/publication/angiopoietin-1-mimetic-peptide-promotes-neuroprotection-after-stroke-in-type-1-diabetic-rats/2019-01-08T11:21:21-05:00https://vasomune.com/publication/influenza-lung-injury-mechanisms-and-therapeutic-opportunities/2019-01-08T16:35:17-05:00https://vasomune.com/publication/the-ten-studies-that-should-be-done-in-ards/2019-01-08T16:36:11-05:00https://vasomune.com/publication/health-care-utilization-and-the-cost-of-posttraumatic-acute-respiratory-distress-syndrome-care/2019-01-08T16:36:48-05:00https://vasomune.com/publication/lessons-to-learn-from-epidemiologic-studies-in-ards/2019-01-08T16:37:41-05:00https://vasomune.com/publication/epidemiology-patterns-of-care-and-mortality-for-patients-with-acute-respiratory-distress-syndrome-in-intensive-care-units-in-50-countries/2019-01-08T16:38:26-05:00https://vasomune.com/publication/acute-respiratory-distress-syndrome-advances-in-diagnosis-and-treatment/2019-01-08T16:39:04-05:00https://vasomune.com/publication/acute-respiratory-distress-syndrome-the-berlin-definition/2019-01-08T16:39:40-05:00https://vasomune.com/publication/acute-respiratory-distress-syndrome/2019-01-08T16:40:10-05:00https://vasomune.com/publication/tie2-activation-promotes-protection-and-reconstitution-of-the-endothelial-glycocalyx-in-human-sepsis/2020-02-26T18:53:47-05:00https://vasomune.com/publication/vasomune-article-in-insights-magazine/2022-04-29T10:49:21-04:00https://vasomune.com/publication/vasomune-therapeutics-receives-us-fda-fast-track-designation-for-novel-investigational-medicine-av-001/2024-05-28T09:15:27-04:00https://vasomune.com/publication/a-randomized-double-blind-placebo-controlled-phase1-single-and-multiple-dose-pharmacokinetic-first-in-human-study-of-av-001-in-health-y-subjects-for-the-treatment-of-acute-respiratory-distress-syndr/2025-09-26T19:35:28-04:00